Top 5 Drug Type | Count |
---|---|
Small molecule drug | 24 |
Herbal medicine | 11 |
Monoclonal antibody | 2 |
Chemical drugs | 1 |
Target- |
Mechanism- |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. China |
First Approval Date31 Oct 2021 |
Target- |
Mechanism- |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. China |
First Approval Date21 Sep 2020 |
Target- |
Mechanism- |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. China |
First Approval Date02 Jun 2020 |
Start Date07 Mar 2025 |
Sponsor / Collaborator |
Start Date27 Feb 2025 |
Sponsor / Collaborator |
Start Date17 Dec 2024 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Shugan Granules | Flank Pain More | Approved |
Sanjiu Weitai Capsule | Gastralgia More | Approved |
Artemisinin | Malaria More | Approved |
Cinobufagin Oral Liquid | Hepatitis B, Chronic More | Approved |
Artemether/Lumefantrine ( ATP2A1 x SERCA2 ) | Malaria More | Approved |